NCT00858143
Non Interventional Study For Patients Treated With Somavert® No drug interventions Not Available Not Available completed NCT03158090
The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research No drug interventions Not Available Not Available recruiting NCT00376064
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly No drug interventions treatment 4 completed NCT04844164
Vitamin D Metabolism in Patients With Endocrine Disorders No drug interventions basic_science 1 completed NCT00642421
Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients No drug interventions treatment 3 terminated NCT01265121
Sleep Apnea Syndrome on Acromegaly: Impact of the Treatment on the Carbohydrates Metabolism. No drug interventions supportive_care Not Available unknown_status NCT03045302
Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly No drug interventions treatment 2 terminated NCT01333384
Study in Polish Acromegalic Patients Treated With Somatuline Autogel No drug interventions Not Available Not Available completed NCT00225979
Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly No drug interventions treatment 3 completed NCT00647179
Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment No drug interventions Not Available Not Available completed NCT00658879
Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan No drug interventions Not Available Not Available completed NCT01368133
The Observational Study of Growth Hormone-secreting Pituitary Tumors No drug interventions Not Available Not Available unknown_status NCT00915954
Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT) No drug interventions other Not Available completed NCT00552851
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant treatment 4 unknown_status NCT00616551
Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients treatment 3 completed NCT03252353
Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly treatment 3 unknown_status NCT06326853
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models No drug interventions Not Available Not Available not_yet_recruiting NCT02396953
Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly treatment 1 / 2 completed NCT00690898
Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma treatment 3 completed NCT00216398
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR No drug interventions treatment 4 completed NCT01471405
One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma No drug interventions Not Available Not Available completed NCT06253897
A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly No drug interventions Not Available Not Available recruiting NCT01819883
Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly No drug interventions Not Available Not Available completed NCT03673761
Muscle in Acromegaly and Cushing's Syndrome No drug interventions Not Available Not Available unknown_status NCT01794793
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies treatment 4 completed NCT02231593
SAGIT for Classification of Patients With Acromegaly in Clinical Practice No drug interventions Not Available Not Available completed NCT00552071
Ultrasound Guided Octreotide LAR Injection in Acromegaly treatment 4 completed NCT00934271
Fractionated Stereotactic Radiotherapy in Patients With Acromegaly No drug interventions Not Available Not Available completed NCT02005978
Brain-gut Interaction in Irradiated Patients With Acromegaly No drug interventions Not Available Not Available unknown_status NCT00149188
Somatuline Autogel: Acromegaly Self/Partner Injection Study No drug interventions treatment 4 completed NCT00921609
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly No drug interventions Not Available Not Available active_not_recruiting NCT02685709
Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly treatment 3 completed NCT00993356
Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas treatment 2 unknown_status NCT03789656
An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge) treatment 2 completed NCT00151437
Canadian Pegvisomant Compassionate Study In Acromegalic Patients No drug interventions treatment 4 completed NCT00128232
Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients No drug interventions treatment 3 completed NCT06372652
A Phase 1 Study of TE-8214 Solution in Healthy Volunteers No drug interventions treatment 1 not_yet_recruiting NCT00663000
Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance No drug interventions Not Available Not Available completed NCT05131100
Korean Regulatory Post Marketing Surveillance for Somavert Not Available Not Available recruiting NCT00747500
Non Interventional Post Marketing Programme in Acromegaly No drug interventions Not Available Not Available completed NCT00521300
Preoperative Octreotide Treatment of Acromegaly treatment 4 completed NCT00005100
Measurement of Outcome of Surgical Treatment in Patients With Acromegaly No drug interventions Not Available Not Available unknown_status NCT02217800
The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics treatment 2 completed NCT00068042
A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly No drug interventions treatment 4 completed NCT01504399
Rhinological Outcomes in Endonasal Pituitary Surgery No drug interventions Not Available Not Available completed NCT02934399
Dynamic Hormone Diagnostics in Endocrine Disease No drug interventions Not Available Not Available completed NCT01732406
Acromegaly Treatment Quality of Life Study No drug interventions Not Available Not Available completed NCT02115906
Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly No drug interventions Not Available Not Available unknown_status NCT03967249
Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands treatment 2 completed NCT00461149
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly No drug interventions treatment 4 completed NCT04003519
Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly No drug interventions Not Available Not Available withdrawn NCT00242541
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas No drug interventions treatment 4 terminated NCT01995734
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly Not Available Not Available approved_for_marketing NCT00143416
Long Term Study With B2036-PEG No drug interventions treatment 3 completed NCT00916916
Lanreotide Levels in Acromegaly No drug interventions Not Available Not Available unknown_status NCT02296216
Late Effects of Radiosurgery on Acromegaly Study No drug interventions other Not Available completed NCT00701363
Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects treatment 4 completed NCT00600886
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly treatment 3 completed NCT03043586
Treatment Patterns and Treatment Outcomes for Acromegaly No drug interventions Not Available Not Available active_not_recruiting NCT02948322
Cardiac (CMRI) Assessment of Acromegaly other Not Available completed NCT05752825
Acromegaly: Balance, Falls and Fracture Risk No drug interventions Not Available Not Available completed NCT00686348
Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study No drug interventions Not Available Not Available completed NCT00210457
Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients No drug interventions treatment 3 completed NCT02371057
Acromegaly & Sleep Apnoea No drug interventions Not Available Not Available completed NCT02396966
Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment. No drug interventions Not Available Not Available completed NCT01538966
Acromegaly Combination Treatment Study treatment Not Available terminated NCT00635765
Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients No drug interventions treatment 3 completed NCT00642720
Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients treatment 4 completed NCT01902420
Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly No drug interventions Not Available Not Available unknown_status NCT05192382
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) treatment 3 active_not_recruiting NCT01086982
Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ® treatment 1 suspended NCT02539927
Validation Study of the SAGIT® Instrument in Acromegaly No drug interventions Not Available Not Available completed NCT00500227
Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery No drug interventions Not Available Not Available completed NCT00001860
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly No drug interventions treatment 2 completed NCT03571594
A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers treatment 1 terminated NCT00182091
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency No drug interventions treatment Not Available completed NCT04076462
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly treatment 3 completed NCT02092129
Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly. No drug interventions Not Available Not Available unknown_status NCT01062529
Peripheral Metabolic Effects of Somatostatin basic_science Not Available completed NCT02111044
Phase II Study With ITF2984 in Acromegalic Patients No drug interventions treatment 2 completed NCT04837040
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly No drug interventions treatment 3 active_not_recruiting NCT00595140
Acute Application of Pegvisomant and Octreotide in Acromegaly No drug interventions treatment 4 completed NCT03474601
Seoul National University Pituitary Disease Cohort Study No drug interventions Not Available Not Available recruiting NCT00615004
Cardiovascular Outcome After Surgery or Somatostatin Analogues No drug interventions Not Available Not Available completed NCT02668172
Pasireotide LAR and Pegvisomant Study in Acromegaly No drug interventions treatment 4 unknown_status NCT01673646
Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism No drug interventions treatment 2 completed NCT05964712
Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study No drug interventions Not Available Not Available recruiting NCT02427295
Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues No drug interventions treatment 4 unknown_status NCT02084095
IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly No drug interventions Not Available Not Available completed NCT05149495
Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery No drug interventions Not Available Not Available unknown_status NCT02403414
Assessment of Airway in Patients With Acromegaly for Predicting Successful Tracheal Intubation No drug interventions Not Available Not Available unknown_status NCT06344650
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess. No drug interventions Not Available Not Available recruiting NCT00765323
Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly No drug interventions treatment 3 terminated NCT01809808
A Prospective Study of Outcome After Therapy for Acromegaly No drug interventions Not Available Not Available active_not_recruiting NCT00383708
Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients No drug interventions treatment 3 completed NCT03401008
Buccodental Manifestations in Patients With Acromegaly No drug interventions Not Available Not Available unknown_status NCT02354508
Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues No drug interventions treatment 3 completed NCT05431803
Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China No drug interventions Not Available Not Available active_not_recruiting NCT01000090
Surgical Versus Medical Treatment of Acromegaly No drug interventions Not Available Not Available completed NCT01752621
Epidemiology of Acromegaly in Denmark 1991-2010 No drug interventions Not Available Not Available unknown_status NCT02698384
Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg No drug interventions Not Available Not Available terminated NCT05401084
Diet in the Management of Acromegaly No drug interventions treatment Not Available recruiting NCT00703079
Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly No drug interventions Not Available Not Available completed NCT00652379
Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients No drug interventions treatment Not Available completed NCT00638287
Inter-Assay Growth Hormone and IGF-I Variability No drug interventions Not Available Not Available withdrawn NCT02235987
Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients. No drug interventions treatment 2 completed NCT02807233
Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects No drug interventions Not Available Not Available completed NCT01371045
Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs No drug interventions Not Available Not Available unknown_status NCT00145405
Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction No drug interventions treatment 4 completed NCT00372697
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly No drug interventions treatment 3 completed NCT02060383
Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly No drug interventions supportive_care 4 completed NCT02274311
Clomiphene Citrate for Treatment of Acromegaly No drug interventions treatment 2 completed NCT01014793
Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients No drug interventions Not Available Not Available completed NCT00499993
Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly No drug interventions treatment 3 completed NCT00461188
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA No drug interventions Not Available Not Available recruiting NCT00315107
Estrogen Treatment in Acromegalic Women No drug interventions Not Available 2 unknown_status NCT04529356
The TMS Treatment for Postoperative Headache in GH Tumor No drug interventions treatment Not Available unknown_status NCT02952885
Strict IGF-1 Control in Acromegaly No drug interventions treatment 3 completed NCT03548415
Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands No drug interventions treatment 2 completed NCT04860037
Micromegaly and Discrepancy Between Growth Hormone and IGF1 at the Diagnosis and Follow-up of Acromegalic Patients No drug interventions Not Available Not Available unknown_status NCT04138537
Olfactory Function and Olfactory Bulb Volume in Acromegaly Patients No drug interventions other Not Available completed NCT00004332
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly No drug interventions Not Available Not Available completed NCT01302652
Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment No drug interventions Not Available Not Available completed NCT01261000
Tissue Biomarker for Pegvisomant Action No drug interventions treatment Not Available completed NCT01568359
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors No drug interventions Not Available Not Available completed NCT01029275
Somatostatin Analog Treatment of Acromegaly Before Pituitary Surgery : Comparison With Neurosurgery Alone No drug interventions Not Available Not Available completed NCT01278342
Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients No drug interventions treatment 4 completed NCT02020499
Predictive Factors Study No drug interventions Not Available Not Available terminated NCT00447499
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel No drug interventions treatment 3 completed NCT03710499
Rehabilitation Program in Patients With Acromegaly No drug interventions treatment Not Available unknown_status NCT01840449
Somatuline Predictive Factors in Acromegaly and NET No drug interventions Not Available Not Available completed NCT04125836
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly No drug interventions treatment 3 active_not_recruiting NCT01618513
Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target No drug interventions treatment 4 completed NCT01424241
Effects of Sandostatin LAR® in Acromegaly No drug interventions treatment 4 completed NCT01861717
A Pilot Study of Pre- and Post-operative Use of Somatuline Depot. No drug interventions treatment 4 terminated NCT02493517
Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly No drug interventions treatment 3 completed NCT01412424
Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly No drug interventions treatment 3 completed NCT01612624
Prospective Study on Changes in Acromegaly No drug interventions Not Available Not Available unknown_status NCT02152124
Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism? No drug interventions Not Available Not Available completed NCT05069324
PegvisOMant and the Immune SystEm (PROMISE) No drug interventions Not Available Not Available completed NCT00627796
Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly No drug interventions treatment 4 completed NCT00171886
Octreotide Efficacy and Safety in First-line Acromegalic Patients No drug interventions treatment 4 completed NCT04349839
ACRODAT Prospective Evaluation Study No drug interventions Not Available Not Available active_not_recruiting NCT00171730
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly No drug interventions treatment 2 completed NCT01723748
Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects No drug interventions basic_science Not Available completed NCT03042026
Developing a Simple Recognition System of Acromegaly No drug interventions Not Available Not Available recruiting NCT00234520
A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide No drug interventions Not Available Not Available completed NCT00446082
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease No drug interventions treatment 1 completed NCT00088582
Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients No drug interventions treatment 2 completed NCT01137682
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly No drug interventions treatment 3 completed NCT05184231
Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China No drug interventions Not Available Not Available withdrawn NCT05761431
A Single-dose Study of Octreotide Injection in Healthy Adult Subjects No drug interventions treatment 1 completed NCT00444873
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly No drug interventions treatment 3 completed NCT03431727
Acromegaly - Before and After Treatment No drug interventions Not Available Not Available unknown_status NCT02012127
Description of Sign-and-symptom Associations at Acromegaly Diagnosis. No drug interventions Not Available Not Available completed NCT01295060
Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly No drug interventions treatment 3 terminated NCT00517491
Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG) No drug interventions treatment 2 withdrawn NCT05298891
Hypoproteic Diet in Acromegaly No drug interventions treatment Not Available not_yet_recruiting NCT04522180
A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly No drug interventions treatment 2 completed NCT00068029
Pegvisomant And Sandostatin LAR Combination Study No drug interventions treatment 4 completed NCT02299089
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) No drug interventions treatment 2 completed NCT05364944
A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) No drug interventions treatment 1 active_not_recruiting NCT03225040
Bone MicroArchitecture in Acromegaly No drug interventions Not Available Not Available completed NCT00461240
Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States No drug interventions Not Available Not Available completed NCT02020967
Programme of Acromegaly Screening in Patients With Associated Somatic Disorders No drug interventions Not Available Not Available completed NCT03849872
Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788 No drug interventions treatment 1 completed NCT00234572
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly No drug interventions treatment 2 / 3 completed NCT04066569
Reproducibility and Utility of OGTT in Acromegaly No drug interventions diagnostic Not Available unknown_status NCT04520646
A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy No drug interventions treatment Not Available unknown_status NCT04261712
A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance) No drug interventions treatment 2 active_not_recruiting NCT00001981
The Treatment and Natural History of Acromegaly No drug interventions Not Available Not Available completed NCT00994214
Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly No drug interventions treatment 2 terminated NCT00913055
Open Label Study of Octreotide Implant in Patients With Acromegaly No drug interventions treatment 2 completed NCT03792555
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) No drug interventions treatment 2 completed NCT03613623
Acromegaly: Patient And Physician Perspectives No drug interventions Not Available Not Available completed NCT00616408
Prediction of Tumor Shrinkage in Acromegaly No drug interventions Not Available Not Available completed NCT00531908
Physiopathology of Sodium Retention in Acromegaly No drug interventions treatment Not Available completed